Also listed on AbbVie Inc., an earlier holder on the record. The recorded assignments below show how it moved.
Term ends Nov 30, 2026 · Medium confidence
20-year base term ends Nov 30, 2026
Why Medium: A parent in the chain could not be resolved.
Held by AbbVie Deutschland GmbH & Co. KG
Filed Oct 11, 2016 as application 15/290,699 · Granted Jan 21, 2020
Base term, 20 years from filing
Today
2006
2026
Clock starts
Nov 30, 2006
Nov 30, 2006
Term ends
Nov 30, 2026
Nov 30, 2026
Granted
Jan 21, 2020
Jan 21, 2020
base term
fee events
Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
None
Term adjustment
No prosecution delay on this record.
No effect
Terminal disclaimer
Resolved from the filed document, referencing US 8,987,419, US 9,822,171, to Nov 30, 2026. The term already ends on or before that date, so the cap shortened nothing.
1 of 1
Maintenance fees paid
One maintenance fee can end this term early, the one due 3.5 years from grant; the next one's grace period runs past the term end. This counts it if the record shows it paid.
6
Family applications on record here
Applications sharing this one's continuity chain whose file history this site holds. The family may have others.
This patent's term is its 20-year base term, with no adjustment for prosecution delay. A terminal disclaimer is resolved from the filed document, and it ends no earlier than this term, so it shortens nothing. 1 of 1 maintenance fees is paid so far. Confidence: Medium. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Nov 30, 2006, when application PCT/EP2006/011530, the earliest non-provisional in its chain, was filed (this one was filed Oct 11, 2016); a parent in its chain could not be resolved (the next row) | Nov 30, 2026 | High confidence |
| Continuity chain | A parent in the chain could not be resolved | dated from this application's own claim | Medium confidence |
| Patent term adjustment | None on file | no change | High confidence |
| Terminal disclaimer cap | Disclaimer resolved from the filed document (refs US 8,987,419, US 9,822,171) | resolves to Nov 30, 2026, no earlier than this term, so no change | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 1 of 1 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | Nov 30, 2026 | Medium confidence |
This family
| US 7,728,031 | Lapsed on the fee record Jun 2022 | Jun 2022 |
| US 8,691,224 | Lapsed on the fee record Apr 2026 | Apr 2026 |
| US 8,399,468 | Lapsed on the fee record Mar 2025 | Mar 2025 |
| US 9,540,432 | In force Apr 2027 | Apr 2027 |
| US 10,538,581 | this patent Nov 2026 | Nov 2026 |
5 of 6 applications in this family shown, earliest filings first. The applications whose file history this site holds. The family may have others.
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| May 2, 2018 Reel 45695, frame 856 | Labkovsky, Boris | AbbVie Inc. | Assignment of Assignor's Interest |
| May 2, 2018 Reel 45696, frame 69 | Barghorn, Stefan; Hillen, Heinz; Striebinger, Andreas R.; Keller, Patrick; Ebert, Ulrich | AbbVie Deutschland GmbH & Co. KG | Assignment of Assignor's Interest |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
What's changing
Nov 2026
Term ends Nov 30, 2026. No further fees fall due before then
Terminal disclaimer
A terminal disclaimer resolved from the filed document, referencing US 8,987,419, US 9,822,171, ends no earlier than this term, so it caps nothing.
Citations
1
later US patent cites this one
That is below the median of utility patents granted in 2020 in our data, the only group it is compared against.
How we rank
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
In force means the term is running and no lapse is on record. It is not a finding that the patent is valid.